Navigation Links
Long-Term Statin Use Won't Raise Cancer Risk: Study
Date:11/10/2010

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, Nov. 10 (HealthDay News) -- Long term use of cholesterol-lowering drugs called statins does not increase the risk of cancer and may even decrease users' risks for lymphoma, melanoma and endometrial tumors, a new study finds.

Studies have shown that the short-term use of statins -- drugs such as Crestor, Lipitor and Zocor -- has little effect on the risk of developing cancer, but less was known about the their use over the long term.

But the new 10-year study suggests that "even long-term statin use is unlikely to increase the risk of common cancers," according to lead researcher Eric J. Jacobs, strategic director of pharmacoepidemiology at the American Cancer Society.

Jacobs was scheduled to present the results Tuesday at a cancer prevention-focused meeting of American Association for Cancer Research in Philadelphia.

For the study, Jacobs's team collected data on more than 133,000 participants in the Cancer Prevention Study II Nutrition Cohort. These people completed questionnaires that included questions about a variety of lifestyle and medical factors, including their use of statins.

Over 10 years of follow-up, 15,000 participants developed cancer.

However, the use of a statin for 5 years or more did not affect the risk of developing cancer of the bladder, breast, colon/rectum, lung, pancreas, prostate or kidneys, the researchers found. In fact, long-term statin use appears unlikely to substantially increase or decrease overall cancer risk, the researchers noted.

But there was other good news. Compared to people who did not take the medications, 5 or more years of statin use was associated with a lowering of risk for melanoma, endometrial cancer and non-Hodgkin lymphoma, the team found. For example, odds for endometrial tumors fell by 39 percent among long-term statin users, while the risk for melanoma dropped by 19 percent, the study found.

The lower risk of endometrial cancer and melanoma had not been seen in prior studies, Jacobs said.

Still, "the results of lower risk of melanoma, endometrial cancer and non-Hodgkin lymphoma need to be interpreted cautiously," Jacobs said.

The study was not conclusive, and according to the researchers, the findings deserve further investigation. And experts note that research presented at conferences typically does not undergo the kind of scrutiny given to studies published in leading journals.

One expert took comfort from the results.

"Over the years the issue of statins and cancer has always been there," said Dr. Ronald Goldberg, professor of medicine, biochemistry and molecular biology at the University of Miami Miller School of Medicine. "It's been demonstrated that the lower the LDL ["bad"] cholesterol, the higher the risk of cancer. And because statins lower LDL there was always the question: Are they promoting that relationship?"

Now, the bulk of the evidence suggests that there is no effect of statins in increasing the risk of malignancy, Goldberg said. "By and large, I think the news is reassuring," he said.

More information

For more information on statins, visit the U.S. National Library of Medicine.

SOURCES: Eric J. Jacobs, Ph.D., strategic director, pharmacoepidemiology, American Cancer Society; Ronald Goldberg, M.D., professor of medicine, biochemistry, and molecular biology, University of Miami Miller School of Medicine; Nov. 9, 2010, presentation, American Association for Cancer Research Frontiers in Cancer Prevention Research conference, Nov. 7-10, 2010, Philadelphia


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Spending Months in Space May Cause Long-Term Bone Loss
2. Protein Differences May Explain Long-Term HIV Control
3. Childhood cancer survivors face long-term risk of GI complications, study finds
4. A dry AMD treatment?; some long-term diabetics escape PDR
5. Surgery offers long-term survival for early stage prostate cancer patients
6. Results of the placement of multiple endoscopic stents for postoperative biliary strictures remains excellent after long-term follow-up
7. Long-Term Use of Bone Drugs May Be Linked to Esophageal Cancer
8. Short-Term Overeating Could Make Long-Term Weight Loss Tougher
9. Long-Term Type 1 Diabetes Survivors Give Clues to the Disease
10. Drug-eluting stents confirmed safe, effective for long-term use
11. CLASS Act analysis reveals Americas long-term care future
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Long-Term Statin Use Won't Raise Cancer Risk: Study
(Date:9/25/2017)... ... 25, 2017 , ... Nissar A. Darmani, PhD, has been awarded a record ... chemotherapy-evoked nausea and vomiting. Dr. Darmani is Associate Dean of Basic Medical Sciences ... grant is from the National Cancer Institute (NCI) arm of the National Institutes of ...
(Date:9/25/2017)... ... September 25, 2017 , ... The Byron Eaton Agency, a Birmingham based ... region, is organizing a local charity drive to send money and support to families ... of water have fallen on Houston as a result of Hurricane Harvey, raising water ...
(Date:9/25/2017)... ... September 25, 2017 , ... Introducing Panther, the revolutionary new iPhone case ... platform Kickstarter seeking support for the #WarOnGrime. , Fact: iPhones are 18 ... shockingly revolting, yet true. The Panther iPhone cases are the first weapon in the ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... ... , an international competition, were announced on Friday, September 22 during a gala ... the human resources professionals, teams, achievements and HR-related products and suppliers who help ...
(Date:9/25/2017)... ... 25, 2017 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that two of its leading biologics analytical experts will ... conferences. , At the BEBPA 10th Annual Bioassay Conference, to be held at ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017  Robert G. Szewc, M.D., ... Professional Member in recognition of his contributions to the ... as a Nephrologist at the practice of Kidney and ... kidney care and hypertension solutions. He has worked in ... of career experience, as well as expertise in kidneys, ...
(Date:9/5/2017)... 5, 2017 Sapheneia and Scannerside received FDA ... DoseCheck is a third-party Vendor neutral CT product that ... allows compliance with current MITA standards. ... DoseCheck solution is specifically designed to provide CT operators, ... radiation doses over a predefined threshold. Scannerside Dose Check ...
(Date:9/1/2017)... -- Michael Penna , President and CEO of ... growth in his response to the July 13, 2017, ... a buyer for eMDs. Penna,s company, Complete HealthCare Solutions, ... Added Reseller and national leader in the independent healthcare ... the healthcare market continues to dictate consolidation, healthcare software ...
Breaking Medicine Technology: